TABLE 2

Single- and Dual-Time-Point Imaging SUVs in Patients with Postbiopsy Inflammation

Sample	Average SUV at time:			% Change in average SUV	Histopathologic findings
Sample		1	2	% Change in average SUV	Histopathologic findings
1	1.7	1.4	−0.176	No tumor, Bx Rx +
2	1.1	0.8	−0.273	Benign, Bx Rx +
3	1.5	1.9	0.267	No tumor, Bx Rx +, Ch Inf
4	1.3	1.1	−0.154	No tumor, Bx Rx +
5	1.0	0.7	−0.300	No tumor
6	1.3	1.2	−0.077	No tumor, Bx Rx +
7	1.0	0.8	−0.200	No tumor, Bx Rx +
8	1.0	1.1	0.100	Bx Rx +, proliferative fibroblasts
9	1.6	1.6	0	No tumor, Bx Rx +
10	1.5	1.3	−0.133	No tumor, Bx Rx +
11	1.0	0.8	−0.200	No tumor, Bx Rx +
12	0.8	0.6	−0.250	No tumor, Bx Rx +
13	1.4	1.3	−0.071	No tumor, Bx Rx +
14	1.5	1.4	−0.067	Benign, Bx Rx +
15	2.0	1.9	−0.050	No tumor, Bx Rx +
16	1.5	1.5	0	No tumor, Bx Rx +
17	1.5	1.7	0.133	Bx Rx, foreign-body giant-cell reaction
18	0.5	0.3	−0.400	No tumor, Bx Rx +
Mean	1.29	1.19	−0.103
SD	0.36	0.45	0.166